2018
DOI: 10.1007/978-3-030-01775-0_16
|View full text |Cite
|
Sign up to set email alerts
|

Nanotheranostics-Based Imaging for Cancer Treatment Monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 153 publications
0
1
0
Order By: Relevance
“…From the mid-1990s, nanotechnology has been used in therapeutics to target cancer and since then, nanoparticle-based platforms have gradually increased their complexity and have approached a wider range of diseases and conditions [ 35 ]. Nonetheless, due to their increased complexity, theranostic platforms are to date unavailable for clinical use [ 35 , 36 ]. Despite the great performance showed by many of the developed theranostic nanostructures at a preclinical level, only a few nanomaterials have been evaluated in clinical trials [ 37 ].…”
Section: Graphene-based Magnetic Nanoparticles For Theranosticsmentioning
confidence: 99%
“…From the mid-1990s, nanotechnology has been used in therapeutics to target cancer and since then, nanoparticle-based platforms have gradually increased their complexity and have approached a wider range of diseases and conditions [ 35 ]. Nonetheless, due to their increased complexity, theranostic platforms are to date unavailable for clinical use [ 35 , 36 ]. Despite the great performance showed by many of the developed theranostic nanostructures at a preclinical level, only a few nanomaterials have been evaluated in clinical trials [ 37 ].…”
Section: Graphene-based Magnetic Nanoparticles For Theranosticsmentioning
confidence: 99%